期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 偏慢,4-8周

Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs.

The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.

《組織工程與再生醫(yī)學(xué)雜志》發(fā)表快速而嚴(yán)格的同行評(píng)審研究論文、評(píng)論、臨床病例報(bào)告、觀點(diǎn)和簡(jiǎn)短通訊，主題涉及結(jié)合干細(xì)胞或祖細(xì)胞、生物材料和支架、生長(zhǎng)因子和其他生物活性劑及其各自構(gòu)造的治療方法的開發(fā)。所有論文都應(yīng)涉及對(duì)組織和器官再生或修復(fù)的新臨床方法的開發(fā)有直接或潛在影響的研究。

該雜志是多學(xué)科的，涵蓋了生命科學(xué)和工程原理的結(jié)合，以推進(jìn)醫(yī)學(xué)和臨床策略。該雜志側(cè)重于使用細(xì)胞、材料和生化/機(jī)械因素來開發(fā)恢復(fù)、維持或改善組織或器官功能的生物功能替代品。該雜志發(fā)表關(guān)于任何組織或器官的研究，涵蓋該領(lǐng)域的所有關(guān)鍵方面，包括新生物材料的開發(fā)和支架的加工；使用不同類型的細(xì)胞（主要是干細(xì)胞和祖細(xì)胞）及其在特定生物反應(yīng)器中的培養(yǎng)；相關(guān)動(dòng)物模型的研究；以及在嚴(yán)格的監(jiān)管和道德框架下對(duì)人類患者進(jìn)行的臨床試驗(yàn)。描述使用先進(jìn)方法表征工程組織的稿件也引起了期刊讀者的特別興趣。

《Journal Of Tissue Engineering And Regenerative Medicine》(組織工程與再生醫(yī)學(xué)雜志)編輯部通訊方式為JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。